A detailed history of Nj State Employees Deferred Compensation Plan transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 17,000 shares of ACAD stock, worth $290,190. This represents 0.03% of its overall portfolio holdings.

Number of Shares
17,000
Previous 17,000 -0.0%
Holding current value
$290,190
Previous $276,000 5.43%
% of portfolio
0.03%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 24, 2019

SELL
$23.32 - $28.12 $93,280 - $112,480
-4,000 Reduced 19.05%
17,000 $454,000
Q4 2018

Jan 24, 2019

SELL
$14.32 - $22.92 $157,520 - $252,120
-11,000 Reduced 34.38%
21,000 $340,000
Q3 2018

Oct 16, 2018

SELL
$13.03 - $21.81 $104,240 - $174,480
-8,000 Reduced 20.0%
32,000 $664,000
Q2 2018

Aug 02, 2018

BUY
$15.07 - $22.34 $602,800 - $893,600
40,000 New
40,000 $611,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Nj State Employees Deferred Compensation Plan Portfolio

Follow Nj State Employees Deferred Compensation Plan and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nj State Employees Deferred Compensation Plan, based on Form 13F filings with the SEC.

News

Stay updated on Nj State Employees Deferred Compensation Plan with notifications on news.